UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches

Cell death and differentiation, 2015-01, Vol.22 (1), p.46-57

2015

Volltextzugriff (PDF)

MiR-221 controls CDKN1C p57 and CDKN1B p27 expression in human hepatocellular carcinoma

Oncogene, 2008-09, Vol.27 (43), p.5651-5661

2008

Volltextzugriff (PDF)

Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research

Journal of hepatocellular carcinoma, 2022-01, Vol.9, p.1263-1278

2022

Volltextzugriff (PDF)

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

Gut, 2001-02, Vol.48 (2), p.251-259

2001

Volltextzugriff (PDF)

Sorafenib in patients with hepatocellular carcinoma: 10 years of real life

Annals of oncology, 2019-07, Vol.30, p.iv57-iv57

2019

Volltextzugriff (PDF)

Multicentric prospective study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: results of INNOVATE study

Annals of oncology, 2019-07, Vol.30, p.iv113-iv113

2019

Volltextzugriff (PDF)

MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma

Digestive and liver disease, 2017-02, Vol.49 (1), p.e28-e28

2017

Volltextzugriff (PDF)

Metabolic Reprogramming toward Awarburg Phenotype Characterizes Early Phases of Hepatic Carcinogenesis

Journal of hepatology, 2016, Vol.64 (2), p.S155-S155

2016

Volltextzugriff (PDF)

In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance

Digestive and liver disease, 2016-02, Vol.48, p.e28-e28

2016

Volltextzugriff (PDF)

292 IN HEPATOCELLULAR CARCINOMA MIR-519D IS UPREGULATED BY P53 AND DNA HYPOMETHYLATION

Journal of hepatology, 2012-04, Vol.56, p.S120-S121

2012

Volltextzugriff (PDF)

271 MIR-221/MDM2/P53 CONTROL LOOP SENSITIZES HEPATOCELLULAR CARCINOMA CELLS TO ANTI-CANCER TREATMENTS

Journal of hepatology, 2012-04, Vol.56, p.S113-S113

2012

Volltextzugriff (PDF)

1043 IN HEPATOCELLULAR CARCINOMA miR-494 IS REGULATED BY EPIGENETIC MECHANISMS AND TARGETS p27, PTEN AND PUMA

Journal of hepatology, 2013-04, Vol.58, p.S428-S429

2013

Volltextzugriff (PDF)

Caspase-3 targeting: A further tile sustaining the anti-apoptotic role of miR-221 in hepatocellular carcinoma

Digestive and liver disease, 2014-02, Vol.46, p.e6-e6

2014

Volltextzugriff (PDF)

F-53 In hepatocellular carcinoma miR-494 is regulated by epigenetic mechanisms and targets p27, PTEN and PUMA

Digestive and liver disease, 2013-02, Vol.45, p.S47-S47

2013

Volltextzugriff (PDF)

T-50 In hepatocellular carcinoma miR-519d is upregulated by p53 and DNA hypomethylation

Digestive and liver disease, 2012-02, Vol.44, p.S31-S31

2012

Volltextzugriff (PDF)

T-10 MiR-221/Mdm2/p53 control loop sensitizes hepatocellular carcinoma cells to anti-cancer treatments

Digestive and liver disease, 2012-02, Vol.44, p.S17-S17

2012

Volltextzugriff (PDF)

249 CHANGES IN TUMOR STIFFNESS FOR EARLY PREDICTION OF TUMOR RESPONSE TO SORAFENIB: A PROOF-OF-CONCEPT STUDY WITH ELASTOSONOGRAPHY IN AN ANIMAL MODEL OF HEPATOCELLULAR CARCINOMA (HCC)

Journal of hepatology, 2011-03, Vol.54, p.S102-S103

2011

Volltextzugriff (PDF)

209 MICRORNA-519D IS UP-REGULATED IN HEPATOCELLULAR CARCINOMA AND SENSITIZES HCC CELLS TO DOXORUBICIN TREATMENT BY TARGETING CDKN1A/P21

Journal of hepatology, 2011-03, Vol.54, p.S88-S88

2011

Volltextzugriff (PDF)

240 HEPATOCELLULAR CARCINOMA CELL LINES SECRETÓME AS A SOURCE OF POTENTIAL BIOMARKERS

Journal of hepatology, 2011-03, Vol.54, p.S99-S100

2011

Volltextzugriff (PDF)

964 MECHANISMS OF P53 REGULATION BY NOTCH SIGNALLING IN HUMAN HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2010, Vol.52, p.S373-S373

2010

Volltextzugriff (PDF)

963 CDKN1C/P57 INDUCES CELL SENESCENCE AND IS REGULATED BY NOTCH TARGET GENE HES1, A PROGNOSTIC FACTOR IN HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2010, Vol.52, p.S372-S373

2010

Volltextzugriff (PDF)

933 MICRORNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT

Journal of hepatology, 2010, Vol.52, p.S361-S362

2010

Volltextzugriff (PDF)

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions

Journal of hepatocellular carcinoma, 2021-01, Vol.8, p.741-757

2021

Volltextzugriff (PDF)

F-3 Notch3 silencing and sorafenib as combinate treatment for human hepatocellular carcinoma

Digestive and liver disease, 2012-02, Vol.44, p.S32-S32

2012

Volltextzugriff (PDF)

Changes in Tumor Stiffness for Early Prediction of Tumor Response to Sorafenib: A Proof-of-Concept Study with Elastosonography in an Animal Model of Hepatocellular Carcinoma (HCC)

Ultrasound in medicine & biology, 2011, Vol.37 (8), p.S21-S21

2011

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(106)

Sprache

Englisch
(106)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(40)
Humans
(39)
Gastroenterology And Hepatology
(32)
Biological And Medical Sciences
(30)
Female
(28)
Medical Sciences
(28)
Male
(27)
Middle Aged
(26)
Gastroenterology & Hepatology
(19)
Adult
(18)
Aged
(17)
Gastroenterology. Liver. Pancreas. Abdomen
(16)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(15)
Hepatocellular Carcinoma
(14)
Tumors
(12)
Oncology
(11)
Carcinoma, Hepatocellular - Pathology
(9)
Liver Cirrhosis - Complications
(9)
Liver Neoplasms - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches

MiR-221 controls CDKN1C p57 and CDKN1B p27 expression in human hepatocellular carcinoma

Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

Sorafenib in patients with hepatocellular carcinoma: 10 years of real life

Multicentric prospective study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: results of INNOVATE study

MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma

Metabolic Reprogramming toward Awarburg Phenotype Characterizes Early Phases of Hepatic Carcinogenesis

In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance

292 IN HEPATOCELLULAR CARCINOMA MIR-519D IS UPREGULATED BY P53 AND DNA HYPOMETHYLATION

271 MIR-221/MDM2/P53 CONTROL LOOP SENSITIZES HEPATOCELLULAR CARCINOMA CELLS TO ANTI-CANCER TREATMENTS

1043 IN HEPATOCELLULAR CARCINOMA miR-494 IS REGULATED BY EPIGENETIC MECHANISMS AND TARGETS p27, PTEN AND PUMA

Caspase-3 targeting: A further tile sustaining the anti-apoptotic role of miR-221 in hepatocellular carcinoma

F-53 In hepatocellular carcinoma miR-494 is regulated by epigenetic mechanisms and targets p27, PTEN and PUMA

T-50 In hepatocellular carcinoma miR-519d is upregulated by p53 and DNA hypomethylation

T-10 MiR-221/Mdm2/p53 control loop sensitizes hepatocellular carcinoma cells to anti-cancer treatments

249 CHANGES IN TUMOR STIFFNESS FOR EARLY PREDICTION OF TUMOR RESPONSE TO SORAFENIB: A PROOF-OF-CONCEPT STUDY WITH ELASTOSONOGRAPHY IN AN ANIMAL MODEL OF HEPATOCELLULAR CARCINOMA (HCC)

209 MICRORNA-519D IS UP-REGULATED IN HEPATOCELLULAR CARCINOMA AND SENSITIZES HCC CELLS TO DOXORUBICIN TREATMENT BY TARGETING CDKN1A/P21

240 HEPATOCELLULAR CARCINOMA CELL LINES SECRETÓME AS A SOURCE OF POTENTIAL BIOMARKERS

964 MECHANISMS OF P53 REGULATION BY NOTCH SIGNALLING IN HUMAN HEPATOCELLULAR CARCINOMA

963 CDKN1C/P57 INDUCES CELL SENESCENCE AND IS REGULATED BY NOTCH TARGET GENE HES1, A PROGNOSTIC FACTOR IN HEPATOCELLULAR CARCINOMA

933 MICRORNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions

F-3 Notch3 silencing and sorafenib as combinate treatment for human hepatocellular carcinoma

Changes in Tumor Stiffness for Early Prediction of Tumor Response to Sorafenib: A Proof-of-Concept Study with Elastosonography in an Animal Model of Hepatocellular Carcinoma (HCC)

Suchergebnisse filtern